Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2016

Mar 15, 2016

30339_dirs_2016-03-15_ab5240c0-4b13-4192-9e8f-496b89daa37a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2016-02-23

Reporting Person: Green Eric Mark (Chief Executive Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-02-23 Common Stock A 2205.0000 $59.6400 Acquired 51118.7720 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-02-23 Stock Option (Right to Buy) $59.6400 A 86732.0000 Acquired 2026-02-23 Common Stock (86732.0000) Direct

Footnotes

F1: Original filing contained incorrect number of options granted, correct number now reflected on this report.